Indian diabetic population on Human Mixtard concerned on changes in insulin therapy: Nandita Vijayasimha, Bengaluru Thursday, April 24, 2025, 08:00 Hrs [IST] India’s diabetic po ...

A WOMAN has shared what happened to her once she had stopped taking fats jabs. As a growing number of people and celebrities share their epic Mounjaro transformations, mum-of-three Mary has ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

CHRISTINA Park had struggled with yo-yo dieting for years – trapped in a vicious cycle of losing 4 to 8lb, then putting on 6 ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

A potentially revolutionary daily weight loss pill could eliminate the need for jabs in patients with type 2 diabetes, a study suggests. The promising medication is the first oral version of a GLP-1 ...